LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

Search

Kala Pharmaceuticals Inc

Atidarymo kaina

0.24 -29.41

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.24

Max

0.34

Pagrindiniai rodikliai

By Trading Economics

Pajamos

3.6M

-7.6M

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-30

Kala Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-04 23:39; UTC

Karštos akcijos

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

2026-03-04 23:20; UTC

Uždarbis

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

2026-03-04 21:43; UTC

Uždarbis

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

2026-03-04 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise After Recent Selloffs -- Market Talk

2026-03-04 23:33; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

2026-03-04 23:24; UTC

Rinkos pokalbiai

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy 4Q EPS C$2.86 >VET

2026-03-04 22:04; UTC

Rinkos pokalbiai

RBA Slipping Behind The Curve On Rates -- Market Talk

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Rev $66.8M >LAC

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Loss/Shr 52c >LAC

2026-03-04 21:52; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:50; UTC

Uždarbis

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

2026-03-04 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q Rev $165.2M >BULL

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q EPS 1c >BULL

2026-03-04 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-04 21:45; UTC

Rinkos pokalbiai

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

2026-03-04 21:40; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:36; UTC

Svarbiausios naujienos

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

2026-03-04 21:27; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:17; UTC

Rinkos pokalbiai

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

2026-03-04 21:16; UTC

Uždarbis

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q EPS $1.50 >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Net $7.35B >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Rev $19.31B >AVGO

Akcijų palyginimas

Kainos pokytis

Kala Pharmaceuticals Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Ikimokestinis pelnas

Pardavimai

Skolų palūkanų išlaidos

Veiklos pelnas

$

Apie bendrovę Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat